Overview
Christelle Durebex-Veyrat practices practicing medicine in Geneve, Switzerland.
Her clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Protein Deficiency, and PEPCK 1 Deficiency.
She is actively involved in clinical research, co-authoring 30 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Christelle Durebex-Veyrat
Is Christelle Durebex-Veyrat a top-rated expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)?
MediFind is an objective health platform that identifies experts based on real-world data. Christelle Durebex-Veyrat is classified as an Experienced expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Christelle Durebex-Veyrat participate in research or clinical trials?
Yes. Christelle Durebex-Veyrat has published 30 articles and abstracts on conditions like Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). You can view a list of Christelle Durebex-Veyrat's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Maturity Onset Diabetes of the YoungMs. Durebex-Veyrat isExperienced. Learn about Maturity Onset Diabetes of the Young.
- Non-Alcoholic Fatty Liver DiseaseMs. Durebex-Veyrat isExperienced. Learn about Non-Alcoholic Fatty Liver Disease.
- ObesityMs. Durebex-Veyrat isExperienced. Learn about Obesity.
- PEPCK 1 DeficiencyMs. Durebex-Veyrat isExperienced. Learn about PEPCK 1 Deficiency.
- Primary Lateral SclerosisMs. Durebex-Veyrat isExperienced. Learn about Primary Lateral Sclerosis.
- Protein DeficiencyMs. Durebex-Veyrat isExperienced. Learn about Protein Deficiency.
- Type 2 Diabetes (T2D)Ms. Durebex-Veyrat isExperienced. Learn about Type 2 Diabetes (T2D).